LCID
Lucid Group, Inc.
LCID lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
LOBO
Lobo EV Technologies Ltd.
There isn't enough reported data to score LOBO yet.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
LOBO Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
LOBO's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
LOBO PE Valuation
LOBO has no meaningful PE right now: it lost money over the past year.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
LOBO Forward outlook
There aren't enough analyst estimates for LOBO to show an outlook.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
LOBO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | -$0.52 | -$0.41 |
LOBO and LCID do not have enough comparable growth data to identify a winner.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID's revenue has grown year over year for 11 quarters in a row: $350M last quarter, up 4.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
LOBO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $14.6M | +21% |
| Q4 2025 | $11.1M | +23% |
| Q2 2025 | $12.1M | -0.3% |
| Q4 2024 | $9.1M | +23% |
| Q2 2024 | $12.1M | +49% |
| Q4 2023 | $7.3M | -43% |
| Q2 2023 | $8.1M | +48% |
| Q4 2022 | $12.8M | +120% |
LOBO has the edge over LCID in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -4.2% | -3.5 points |
| Q4 2025 | -26% | -31 points |
| Q2 2025 | -9.5% | -15 points |
| Q4 2024 | -20% | -31 points |
| Q2 2024 | -0.7% | -5.2 points |
| Q4 2023 | 5.2% | -10 points |
| Q2 2023 | 5.4% | -11 points |
| Q4 2022 | 10% | N/A |
LOBO has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
LOBO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$3.8M | -$2.5M |
| Q4 2025 | -$819.4K | +$1.3M |
| Q2 2025 | -$1.3M | -$141.6K |
| Q4 2024 | -$2.1M | -$511.3K |
| Q2 2024 | -$1.2M | -$1M |
| Q4 2023 | -$1.6M | +$2.9K |
| Q2 2023 | -$149.1K | +$225.9K |
| Q4 2022 | -$1.6M | -155% |
LOBO has burned cash in almost every quarter: −$8M over the past year, against −$4M the year before.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has the edge over LOBO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
LOBO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +41% | +4.2M shares |
| 1 year | +105% | +7.5M shares |
LOBO has 15M diluted shares, up 105% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q4 2023 | — |
| Q2 2023 | — |
| Q4 2022 | — |
| Q2 2022 | — |
| Q4 2021 | — |
| Q2 2021 | — |
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LOBO Net Leverage
LOBO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
LOBO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.9 | Neutral |
| Stochastic | 0.9 | Oversold |
LOBO's weekly RSI is 31 (neutral) and its Stochastic is 1 (oversold).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
LOBO PE vs Consumer Cyclical Sector
| Metric | LOBO | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
LOBO has no meaningful PE right now: it lost money over the past year.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LOBO has stronger trend alignment. LCID is above 0 of 5 weekly averages versus LOBO above 0 of 4.
LOBO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.45 | 20% below |
| 20 week MA | $0.57 | 37% below |
| 50 week MA | $0.61 | 41% below |
| 100 week MA | $0.78 | 54% below |
LOBO is in a downtrend: it's below all four of its weekly moving averages, and 54% below its 100-week average.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
LOBO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $3.50 | $1.95 | -44% |
| 2025 | $1.95 | $0.69 | -65% |
| 2026 YTD | $0.69 | $0.36 | -48% |
LOBO has the edge over LCID on returns for 2026, with the stronger performance.